WHO ICTRP trial
Investigating the effect of triamcinolone acetate injection in the lower…
IRCT20171008036655N2 · Iranian Registry of Clinical Trials (IRCT) · Recruiting
Key facts
| Trial ID | IRCT20171008036655N2 |
|---|---|
| Public title | Investigating the effect of triamcinolone acetate injection in the lower branches of the nose in improving the symptoms and quality of life of patients with allergic rhinitis undergoing rhinoplasty |
| Scientific title | Investigating the effect of triamcinolone acetate injection in the lower branches of the nose in improving the symptoms and quality of life of patients with allergic rhinitis undergoing rhinoplasty |
| Primary sponsor | Zahedan University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Recruiting |
| Study type | interventional |
| Phase | 2-3 |
| Countries | Iran (Islamic Republic of) |
| Conditions | allergic rhinitis. Other allergic rhinitis |
| Interventions | Intervention 1: Intervention group: In the intervention group, 20 mg of triamcinolone will be given intraoperatively in each lower nasal concha. Intervention 2: Control group: No drugs will be used. |
| Registration date | Feb 23, 2018 |
| Target size | 100 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: